Press release
Ophthalmic Drugs Market Share 2023: Trends, Key Players, Industry Analysis and Forecast 2023-2029
The global ophthalmic drugs market is projected to grow at a significant CAGR of around 5% during the forecast period. The market growth is attributed to the increasing prevalence of various eye disorders that increase the demand for efficient treatment and hence drives the growth of the global ophthalmic drugs market.Geographically, the global ophthalmic drugs industry is segmented into North America, Europe, Asia-Pacific and the Rest of the World. North America is expected to hold a significant share in the global market during the forecast period. This is attributed to the presence of well-established healthcare infrastructure in the region. In addition, the increased prevalence of ophthalmic disorders, rising prevalence of chronic diseases. The leading causes of blindness in the region include cataract, diabetic retinopathy (DRP), damaged cornea, macular degeneration, glaucoma, refractive errors, and others.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/ophthalmic-drugs-market
Besides, the geriatric population plays a vital role in expanding the market size as this population pool is at increased risk of acquiring eye disorder. According to the Statistics Times, the population of North America as of 2017 was 582.4 million. Half the population of North America is over 40 years of age due to an increase in the average life expectancy of people. As the elder people are more susceptible to cataracts and other eye-related problems and creates scope for the market growth.
Whereas, the market in Asia-Pacific is driven by numerous factors including increasing government initiatives such as the National Programme for Control of Blindness. As per the estimation of the International Diabetes Federation (IDF) in 2018, 382 million people had diabetes globally, and by 2035, this number was predicted to rise to 592 million. 80% of this population lives in under-developed and developing countries, and of the total, more than 60% live in Asia, with almost one-third in China.
Major increases in the prevalence of diabetes have occurred in developing countries including India and China due to rapid and ongoing socio-economic transition and will likely lead to further rise. According to the International Diabetes Federation, in 2018, 79% of adults with diabetes were living in developing and under-developed countries some of which leads to diabetic retinopathy. Also, the World Health Organization states that China had the largest number with 8 million blind and 75 million visually impaired individuals. Thus, these factors altogether create opportunities for market growth.
Current Market Trends Covered in the Global Ophthalmic Drugs Market Report:
• Increased investments by the government concerning the early diagnosis and treatment of diseases is likely to positively affect the ophthalmic drug industry during the forecast period.
• The Asia-Pacific region will register a significant growth rate in the market during the forecast period.
• Novel product launches and the geographical expansion will be the key growth strategy adopted by the key players to sustain in the market.
Global Ophthalmic Drugs Market - Segmentation
By Indication
• Dry Eye
• Eye Allergy
• Glaucoma
• Eye Infection
• Retinal Disorders
• Others
By Drug Class
• Anti-Glaucoma Drugs
• Anti-Allergy Drugs
• Anti-Inflammatory Drugs
• Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Agents
A full report of Ophthalmic Drugs Market is available at: https://www.omrglobal.com/industry-reports/ophthalmic-drugs-market
Ophthalmic Drugs Market- Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• Acucela Inc.
• AFT Pharmaceuticals Ltd.
• Akron Inc.
• Allergan PLC
• Bayer AG
• Bausch Health Companies Inc.
• Daiichi Sankyo Co. Ltd.
• EyePoint Pharmaceuticals Inc.
• Johnson & Johnson Services Inc.
• Merck & Co., Inc.
• Novartis International AG
• Omeros Corp.
• Otsuka Pharmaceutical Co. Ltd.
• Oxurion NV.
Reasons to Buying From us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Visit More Report at
https://www.asiatimeskorea.com/press-release/%eb%8b%a4%eb%85%84%ec%83%9d-%ec%95%8c%eb%a0%88%eb%a5%b4%ea%b8%b0-%eb%b9%84%ec%97%bc-%ec%95%bd%eb%ac%bc-%ec%8b%9c%ec%9e%a5-%eb%8f%99%ed%96%a5-%ec%97%b0%ea%b5%ac-%eb%b3%b4%ea%b3%a0%ec%84%9c-%ec%84%b1/214465/
https://www.diario-ya.com/regionales/%e8%9b%8b%e7%99%bd%e8%b4%a8%e8%b0%b7%e6%b0%a8%e9%85%b0%e8%83%ba%e4%bc%bd%e7%8e%9b%e8%b0%b7%e6%b0%a8%e9%85%b0%e8%bd%ac%e7%a7%bb%e9%85%b6-2-%e5%b8%82%e5%9c%ba%e8%b6%8b%e5%8a%bf%e3%80%81%e7%a0%94/288342/
https://sportmsr.com/%d8%a7%d9%84%d8%ad%d8%b5%d8%a9-%d8%a7%d9%84%d8%b3%d9%88%d9%82%d9%8a%d8%a9-%d9%84%d8%a3%d9%82%d8%b1%d8%a7%d8%b5-%d8%a7%d9%84%d8%b2%d8%b9%d9%81%d8%b1%d8%a7%d9%86-%d9%81%d9%8a-%d8%b9%d8%a7%d9%85-2022/
https://revistaeconomiasocial.com/2022/12/30/informe-de-mercado-de-medicamentos-para-la-esclerosis-multiple-progresiva-secundaria-2022-por-jugadores-clave-tendencias-tamano-participacion-y-pronostico-2022-2028/
https://monblogapple.com/2022/12/30/rapport-sur-le-marche-de-la-proteine-de-surface-gp-120-2022-par-acteurs-cles-tendances-taille-part-et-previsions-2022-2028/
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ophthalmic Drugs Market Share 2023: Trends, Key Players, Industry Analysis and Forecast 2023-2029 here
News-ID: 2971179 • Views: …
More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…

Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…

Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…

Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…